Company: NOTV
Filing Date: 2025-01-23
Form Type: DEF 14A
Source: 0001628280-25-002250
Chunk: 47

Company: Inotiv, Inc.
Filing Date: 2025-01-23
Form: DEF 14A
Chunk 47
---
 the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, as described above.

| Name                               |     | Grant date |     |           | Number of securities underlying the award |         |     | Exercise price of the award ($/Sh) |      |     | Grant date fair value of the award |         |     | Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information |      |   |
|:-----------------------------------|:----|:-----------|:----|:----------|:------------------------------------------|--------:|:----|:-----------------------------------|-----:|:----|:-----------------------------------|--------:|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----:|:--|
| Robert W. Leasure, Jr.             |     |            |     | 8/10/2024 |                                           | 300,000 |     | $                                  | 1.61 |     | $                                  | 366,028 |     |                                                                                                                                                                                                                                                                                                | -0.6 | % |
| Beth A. Taylor                     |     |            |     | 8/10/2024 |                                           |  20,000 |     | $                                  | 1.61 |     | $                                  |  24,402 |     |                                                                                                                                                                                                                                                                                                | -0.6 | % |
| John E. Sagartz, DVM, Ph.D., DACVP |     |            |     | 8/10/2024 |                                           |  20,000 |     | $                                  | 1.61 |     | $                                  |  24,402 |     |                                                                                                                                                                                                                                                                                                | -0.6 | % |

<div align='center'>27</div>

#### Fiscal 2024 Summary Compensation Table
Individual components of the total compensation calculation reflected in the Summary Compensation Table are broken out below:

Salary. Base salary earned during fiscal 2024 and 2023.

Bonus. The amounts presented under the Bonus column represent discretionary bonus amounts with respect to performance in the fiscal year shown, though are typically paid in the following fiscal year.

Non-Equity Incentive Plan Compensation. The amounts presented under the Non-Equity Incentive Plan Compensation column represent bonus amounts under a program that provides for compensation intended to serve as incentive for performance to occur